# pathway_0074

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MPSATPVIPSQQTAIVAEGAGQLSIYHDAPVPALQPDVALVKTAAVAINPVDAKMLDYSPVPGAIHGYDFAGTIVALGSDTPPHLKVGDRVAGFVHGMNPLLPDVGAFAEYVAASADLVLKLPDTMSFEEGASLGLGLFTAGLGLFQHLQIPLSLTREPSPEASSPTKADFVLVAGGSTATGTRALQLLKLAGLRPVATCSPAHFDLARRFGAEAVFDYHDPDCAAAIRAYTKNTLAYALDCLALAETTQLCYGALGRAGGRYVTLEPFREAIAAQRPHTVTPSWLLALTIFGRKVALDGEYGREANPEDREFGARLTEQVQGLLDEGKVDVHPVRVMGGGWQGVLEGVDLVRRQTVSGHKLVYAV

[Multiple Choices]
A. LPS O-antigen biosynthesis. .
B. glycosylphosphatidylinositol-anchor biosynthesis. .
C. L-methionine biosynthesis via de novo pathway. .
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for CaaB, annotated as a trans-enoyl reductase in the carlosic-acid biosynthesis cluster, with the pathway assigned as secondary metabolite biosynthesis. The pathway annotation is transferred by similarity (ECO:0000250), so this supports the key as an annotation but is not, by itself, proof of direct experimental validation for this protein.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a soluble enzyme, but its features do not establish which metabolic pathway it serves. Identifying it as a reductase in a particular fungal biosynthetic cluster requires protein-specific functional or annotation information.


**Missing item-specific fact**

> That this exact protein is CaaB, associated with the carlosic-acid biosynthesis cluster and annotated to secondary metabolite biosynthesis.


**Reason**

> The input supplies only the sequence and broad pathway choices; it does not provide the protein identity, organism, cluster context, or pathway evidence needed to distinguish the specific pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer-only evidence supports D for this exact sequence. The sequence alone does not distinguish the options, but that lack of supplied evidence does not establish another choice as equally correct.


### Important caveats

- The sequence match applies to the supplied 366-residue sequence.
- The pathway annotation is similarity-transferred; the cited paper concerns acyltetronic-acid derivatives and does not, from the excerpts provided, independently establish direct experimental validation of CaaB's pathway role.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with a soluble enzyme, but its features do not establish which metabolic pathway it serves. Identifying it as a reductase in a particular fungal biosynthetic cluster requires protein-specific functional or annotation information.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this exact protein is CaaB, associated with the carlosic-acid biosynthesis cluster and annotated to secondary metabolite biosynthesis.",
    "reason": "The input supplies only the sequence and broad pathway choices; it does not provide the protein identity, organism, cluster context, or pathway evidence needed to distinguish the specific pathway."
  },
  "case_id": "pathway_0074",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for CaaB, annotated as a trans-enoyl reductase in the carlosic-acid biosynthesis cluster, with the pathway assigned as secondary metabolite biosynthesis. The pathway annotation is transferred by similarity (ECO:0000250), so this supports the key as an annotation but is not, by itself, proof of direct experimental validation for this protein."
  },
  "important_caveats": [
    "The sequence match applies to the supplied 366-residue sequence.",
    "The pathway annotation is similarity-transferred; the cited paper concerns acyltetronic-acid derivatives and does not, from the excerpts provided, independently establish direct experimental validation of CaaB's pathway role."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only evidence supports D for this exact sequence. The sequence alone does not distinguish the options, but that lack of supplied evidence does not establish another choice as equally correct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0074",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for CaaB, annotated as a trans-enoyl reductase in the carlosic-acid biosynthesis cluster, with the pathway assigned as secondary metabolite biosynthesis. The pathway annotation is transferred by similarity (ECO:0000250), so this supports the key as an annotation but is not, by itself, proof of direct experimental validation for this protein.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a soluble enzyme, but its features do not establish which metabolic pathway it serves. Identifying it as a reductase in a particular fungal biosynthetic cluster requires protein-specific functional or annotation information.",
    "missing_item_specific_fact": "That this exact protein is CaaB, associated with the carlosic-acid biosynthesis cluster and annotated to secondary metabolite biosynthesis.",
    "reason": "The input supplies only the sequence and broad pathway choices; it does not provide the protein identity, organism, cluster context, or pathway evidence needed to distinguish the specific pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only evidence supports D for this exact sequence. The sequence alone does not distinguish the options, but that lack of supplied evidence does not establish another choice as equally correct."
  },
  "important_caveats": [
    "The sequence match applies to the supplied 366-residue sequence.",
    "The pathway annotation is similarity-transferred; the cited paper concerns acyltetronic-acid derivatives and does not, from the excerpts provided, independently establish direct experimental validation of CaaB's pathway role."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A2QQU5 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (C5, H3). The protein is Trans-enoyl reductase caaB, part of the carlosic acid biosynthesis cluster in Aspergillus niger. Carlosic acid is a noncanonical cryptic polyketide (a secondary metabolite), confirmed experimentally by PubMed:25044953 (C6, H2). The pathway annotation uses ECO:0000250 (similarity), but the underlying function and pathway are supported by the cited experimental study.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a recognizable NAD(P)-dependent enoyl reductase domain (the 'GGGWQGVLEGVDLVRRQ' region with Rossmann-fold-like architecture and the 'AGGSTATGTRALQ' nucleotide-binding motif). Enoyl reductase domains are hallmark catalytic modules of modular polyketide synthases (PKS), which are the defining enzymes of polyketide (secondary metabolite) biosynthesis in fungi. This distinguishes the protein from primary metabolic reductases: homoserine dehydrogenase in methionine biosynthesis (option C) has a distinct LDH-like fold, and GPI-anchor or LPS biosynthesis enzymes (options A, B) are glycosyltransferases or phosphatases, not NAD(P)-dependent reductases of this architecture. Recognizing the enoyl reductase domain as a PKS component is a standard domain-architecture inference.


**Missing item-specific fact**

> None strictly required; however, the model must correctly identify the enoyl reductase domain architecture and associate it with fungal polyketide synthases rather than other NAD(P)-dependent reductases.


**Reason**

> The sequence provides identifiable domain features (enoyl reductase / NAD(P)-binding motifs) that, through general knowledge of PKS domain organization in fungi, point to secondary metabolite biosynthesis. The distractors represent mechanistically distinct enzyme classes (glycosyltransferases for LPS/GPI, PLP-dependent or LDH-like enzymes for methionine) that do not match the observed domain architecture. This is a legitimate structural-enzymatic inference rather than pure database lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The enoyl reductase domain architecture is specific to polyketide synthases and does not match the enzyme classes involved in LPS O-antigen biosynthesis (glycosyltransferases/polymerases), GPI-anchor biosynthesis (phosphatases/glycosyltransferases), or L-methionine biosynthesis (homoserine dehydrogenase with LDH-like fold, cystathionine gamma-synthase with PLP fold). Only option D is consistent with the observed domain.


### Important caveats

- The UniProt pathway annotation carries ECO:0000250 (inferred by similarity to A0A0E0RXA7), not direct experimental evidence for this specific entry, though the cited PubMed study (25044953) provides experimental confirmation of function and pathway.
- The organism (Aspergillus niger, a fungus) is not stated in the question; however, the enoyl reductase domain reasoning does not strictly require organism knowledge, as enoyl reductase domains are primarily PKS-associated across taxa.
- The reviewer-only evidence was absent from the evaluated model input; the reasoning assessment is based solely on the sequence and choices provided.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a recognizable NAD(P)-dependent enoyl reductase domain (the 'GGGWQGVLEGVDLVRRQ' region with Rossmann-fold-like architecture and the 'AGGSTATGTRALQ' nucleotide-binding motif). Enoyl reductase domains are hallmark catalytic modules of modular polyketide synthases (PKS), which are the defining enzymes of polyketide (secondary metabolite) biosynthesis in fungi. This distinguishes the protein from primary metabolic reductases: homoserine dehydrogenase in methionine biosynthesis (option C) has a distinct LDH-like fold, and GPI-anchor or LPS biosynthesis enzymes (options A, B) are glycosyltransferases or phosphatases, not NAD(P)-dependent reductases of this architecture. Recognizing the enoyl reductase domain as a PKS component is a standard domain-architecture inference.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; however, the model must correctly identify the enoyl reductase domain architecture and associate it with fungal polyketide synthases rather than other NAD(P)-dependent reductases.",
    "reason": "The sequence provides identifiable domain features (enoyl reductase / NAD(P)-binding motifs) that, through general knowledge of PKS domain organization in fungi, point to secondary metabolite biosynthesis. The distractors represent mechanistically distinct enzyme classes (glycosyltransferases for LPS/GPI, PLP-dependent or LDH-like enzymes for methionine) that do not match the observed domain architecture. This is a legitimate structural-enzymatic inference rather than pure database lookup."
  },
  "case_id": "pathway_0074",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A2QQU5 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (C5, H3). The protein is Trans-enoyl reductase caaB, part of the carlosic acid biosynthesis cluster in Aspergillus niger. Carlosic acid is a noncanonical cryptic polyketide (a secondary metabolite), confirmed experimentally by PubMed:25044953 (C6, H2). The pathway annotation uses ECO:0000250 (similarity), but the underlying function and pathway are supported by the cited experimental study."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries ECO:0000250 (inferred by similarity to A0A0E0RXA7), not direct experimental evidence for this specific entry, though the cited PubMed study (25044953) provides experimental confirmation of function and pathway.",
    "The organism (Aspergillus niger, a fungus) is not stated in the question; however, the enoyl reductase domain reasoning does not strictly require organism knowledge, as enoyl reductase domains are primarily PKS-associated across taxa.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning assessment is based solely on the sequence and choices provided."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain architecture is specific to polyketide synthases and does not match the enzyme classes involved in LPS O-antigen biosynthesis (glycosyltransferases/polymerases), GPI-anchor biosynthesis (phosphatases/glycosyltransferases), or L-methionine biosynthesis (homoserine dehydrogenase with LDH-like fold, cystathionine gamma-synthase with PLP fold). Only option D is consistent with the observed domain."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0074",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A2QQU5 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (C5, H3). The protein is Trans-enoyl reductase caaB, part of the carlosic acid biosynthesis cluster in Aspergillus niger. Carlosic acid is a noncanonical cryptic polyketide (a secondary metabolite), confirmed experimentally by PubMed:25044953 (C6, H2). The pathway annotation uses ECO:0000250 (similarity), but the underlying function and pathway are supported by the cited experimental study.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a recognizable NAD(P)-dependent enoyl reductase domain (the 'GGGWQGVLEGVDLVRRQ' region with Rossmann-fold-like architecture and the 'AGGSTATGTRALQ' nucleotide-binding motif). Enoyl reductase domains are hallmark catalytic modules of modular polyketide synthases (PKS), which are the defining enzymes of polyketide (secondary metabolite) biosynthesis in fungi. This distinguishes the protein from primary metabolic reductases: homoserine dehydrogenase in methionine biosynthesis (option C) has a distinct LDH-like fold, and GPI-anchor or LPS biosynthesis enzymes (options A, B) are glycosyltransferases or phosphatases, not NAD(P)-dependent reductases of this architecture. Recognizing the enoyl reductase domain as a PKS component is a standard domain-architecture inference.",
    "missing_item_specific_fact": "None strictly required; however, the model must correctly identify the enoyl reductase domain architecture and associate it with fungal polyketide synthases rather than other NAD(P)-dependent reductases.",
    "reason": "The sequence provides identifiable domain features (enoyl reductase / NAD(P)-binding motifs) that, through general knowledge of PKS domain organization in fungi, point to secondary metabolite biosynthesis. The distractors represent mechanistically distinct enzyme classes (glycosyltransferases for LPS/GPI, PLP-dependent or LDH-like enzymes for methionine) that do not match the observed domain architecture. This is a legitimate structural-enzymatic inference rather than pure database lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain architecture is specific to polyketide synthases and does not match the enzyme classes involved in LPS O-antigen biosynthesis (glycosyltransferases/polymerases), GPI-anchor biosynthesis (phosphatases/glycosyltransferases), or L-methionine biosynthesis (homoserine dehydrogenase with LDH-like fold, cystathionine gamma-synthase with PLP fold). Only option D is consistent with the observed domain."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries ECO:0000250 (inferred by similarity to A0A0E0RXA7), not direct experimental evidence for this specific entry, though the cited PubMed study (25044953) provides experimental confirmation of function and pathway.",
    "The organism (Aspergillus niger, a fungus) is not stated in the question; however, the enoyl reductase domain reasoning does not strictly require organism knowledge, as enoyl reductase domains are primarily PKS-associated across taxa.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning assessment is based solely on the sequence and choices provided."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A2QQU5` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 100. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A2QQU5.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:50.908499+00:00.  

```json
"A2QQU5"
```

Source SHA-256: `ec0720d681f22d21e385e54c1260725a15cf2c30e21daab42ba29c923141a8dd`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A2QQU5.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:50.908499+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"25044953","source":"PubMed"}],"value":"Carlosic acid biosynthesis cluster protein B"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"25044953","source":"PubMed"}],"value":"1.-.-.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"25044953","source":"PubMed"}],"value":"Trans-enoyl reductase caaB"}}}
```

Source SHA-256: `ec0720d681f22d21e385e54c1260725a15cf2c30e21daab42ba29c923141a8dd`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A2QQU5.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:50.908499+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"A0A0E0RXA7","source":"UniProtKB"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `ec0720d681f22d21e385e54c1260725a15cf2c30e21daab42ba29c923141a8dd`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A2QQU5.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:50.908499+00:00.  

```json
{"citation":{"authors":["Yang X.L.","Awakawa T.","Wakimoto T.","Abe I."],"citationCrossReferences":[{"database":"PubMed","id":"25044953"},{"database":"DOI","id":"10.1002/cbic.201402172"}],"citationType":"journal article","firstPage":"1578","id":"25044953","journal":"ChemBioChem","lastPage":"1583","publicationDate":"2014","title":"Three acyltetronic acid derivatives: noncanonical cryptic polyketides from Aspergillus niger identified by genome mining.","volume":"15"},"referenceNumber":2,"referencePositions":["FUNCTION","CATALYTIC ACTIVITY","INDUCTION","PATHWAY"]}
```

Source SHA-256: `ec0720d681f22d21e385e54c1260725a15cf2c30e21daab42ba29c923141a8dd`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A2QQU5?format=txt&versions=100)  
**Locator:** `lines 1-14`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 100 / 1.  
**Retrieved:** 2026-11-02T04:26:55.145395+00:00.  

```text
ID   CAAB_ASPNC              Reviewed;         366 AA.
AC   A2QQU5;
DT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   28-JAN-2026, entry version 100.
DE   RecName: Full=Trans-enoyl reductase caaB {ECO:0000303|PubMed:25044953};
DE            EC=1.-.-.- {ECO:0000269|PubMed:25044953};
DE   AltName: Full=Carlosic acid biosynthesis cluster protein B {ECO:0000303|PubMed:25044953};
GN   Name=caaB {ECO:0000303|PubMed:25044953}; ORFNames=An08g03740;
OS   Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=425011;
```

Source SHA-256: `1d9df0690710a301b1081da4f1701485317bbf1008a1422094bc639434427cf1`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A2QQU5?format=txt&versions=100)  
**Locator:** `lines 36-42`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 100 / 1.  
**Retrieved:** 2026-11-02T04:26:55.145395+00:00.  

```text
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND PATHWAY.
RX   PubMed=25044953; DOI=10.1002/cbic.201402172;
RA   Yang X.L., Awakawa T., Wakimoto T., Abe I.;
RT   "Three acyltetronic acid derivatives: noncanonical cryptic polyketides from
RT   Aspergillus niger identified by genome mining.";
RL   ChemBioChem 15:1578-1583(2014).
```

Source SHA-256: `1d9df0690710a301b1081da4f1701485317bbf1008a1422094bc639434427cf1`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A2QQU5?format=txt&versions=100)  
**Locator:** `lines 62-63`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 100 / 1.  
**Retrieved:** 2026-11-02T04:26:55.145395+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000250|UniProtKB:A0A0E0RXA7}.
```

Source SHA-256: `1d9df0690710a301b1081da4f1701485317bbf1008a1422094bc639434427cf1`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 74. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
